Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP302866.RA47vhkn3G5dPSK6qT7kGQznYHQhbS7oA5HtqEDfgq6vI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP302866.RA47vhkn3G5dPSK6qT7kGQznYHQhbS7oA5HtqEDfgq6vI130_assertion type Assertion NP302866.RA47vhkn3G5dPSK6qT7kGQznYHQhbS7oA5HtqEDfgq6vI130_head.
- NP302866.RA47vhkn3G5dPSK6qT7kGQznYHQhbS7oA5HtqEDfgq6vI130_assertion description "[To evaluate whether p21 (WAF-1/CIP1) should be considered a potential candidate for human bladder cancer gene therapy, we determined: (1) the basal level of p21 expression in bladder cancer cell lines, (2) the response of bladder cancer cells to increased p21 expression following p21 adenovirus infection, and (3) the mechanism of growth inhibition produced by p21 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302866.RA47vhkn3G5dPSK6qT7kGQznYHQhbS7oA5HtqEDfgq6vI130_provenance.
- NP302866.RA47vhkn3G5dPSK6qT7kGQznYHQhbS7oA5HtqEDfgq6vI130_assertion evidence source_evidence_literature NP302866.RA47vhkn3G5dPSK6qT7kGQznYHQhbS7oA5HtqEDfgq6vI130_provenance.
- NP302866.RA47vhkn3G5dPSK6qT7kGQznYHQhbS7oA5HtqEDfgq6vI130_assertion SIO_000772 10688044 NP302866.RA47vhkn3G5dPSK6qT7kGQznYHQhbS7oA5HtqEDfgq6vI130_provenance.
- NP302866.RA47vhkn3G5dPSK6qT7kGQznYHQhbS7oA5HtqEDfgq6vI130_assertion wasDerivedFrom befree-20150227 NP302866.RA47vhkn3G5dPSK6qT7kGQznYHQhbS7oA5HtqEDfgq6vI130_provenance.
- NP302866.RA47vhkn3G5dPSK6qT7kGQznYHQhbS7oA5HtqEDfgq6vI130_assertion wasGeneratedBy ECO_0000203 NP302866.RA47vhkn3G5dPSK6qT7kGQznYHQhbS7oA5HtqEDfgq6vI130_provenance.